GB9719238D0 - Viral infection of cells - Google Patents

Viral infection of cells

Info

Publication number
GB9719238D0
GB9719238D0 GBGB9719238.9A GB9719238A GB9719238D0 GB 9719238 D0 GB9719238 D0 GB 9719238D0 GB 9719238 A GB9719238 A GB 9719238A GB 9719238 D0 GB9719238 D0 GB 9719238D0
Authority
GB
United Kingdom
Prior art keywords
cells
viral infection
viral
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9719238.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kennedy Trust for Rheumatology Research
Original Assignee
Mathilda and Terence Kennedy Institute of Rheumatology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mathilda and Terence Kennedy Institute of Rheumatology filed Critical Mathilda and Terence Kennedy Institute of Rheumatology
Priority to GBGB9719238.9A priority Critical patent/GB9719238D0/en
Publication of GB9719238D0 publication Critical patent/GB9719238D0/en
Priority to EP98942892A priority patent/EP1012321A2/en
Priority to PCT/GB1998/002753 priority patent/WO1999013064A2/en
Priority to JP2000510853A priority patent/JP2001515716A/en
Priority to US10/033,267 priority patent/US20020177572A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9719238.9A 1997-09-11 1997-09-11 Viral infection of cells Ceased GB9719238D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9719238.9A GB9719238D0 (en) 1997-09-11 1997-09-11 Viral infection of cells
EP98942892A EP1012321A2 (en) 1997-09-11 1998-09-11 Viral infection of cells using viral vectors
PCT/GB1998/002753 WO1999013064A2 (en) 1997-09-11 1998-09-11 Viral infection of cells using viral vectors
JP2000510853A JP2001515716A (en) 1997-09-11 1998-09-11 Viral infection of cells
US10/033,267 US20020177572A1 (en) 1997-09-11 2001-10-25 Viral infection of cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9719238.9A GB9719238D0 (en) 1997-09-11 1997-09-11 Viral infection of cells

Publications (1)

Publication Number Publication Date
GB9719238D0 true GB9719238D0 (en) 1997-11-12

Family

ID=10818857

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9719238.9A Ceased GB9719238D0 (en) 1997-09-11 1997-09-11 Viral infection of cells

Country Status (4)

Country Link
EP (1) EP1012321A2 (en)
JP (1) JP2001515716A (en)
GB (1) GB9719238D0 (en)
WO (1) WO1999013064A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922281D0 (en) * 1999-09-22 1999-11-17 Kennedy Rheumatology Inst Polymorphism
GB9930616D0 (en) 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0779361A3 (en) * 1995-12-15 1999-11-10 F. Hoffmann-La Roche Ag Truncated form of inhibitory kappa B protein (1kB), recombinant production and uses thereof

Also Published As

Publication number Publication date
JP2001515716A (en) 2001-09-25
WO1999013064A2 (en) 1999-03-18
EP1012321A2 (en) 2000-06-28
WO1999013064A3 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
AP2001002301A0 (en) Inhibition of viral infection using monovalentantigen-binding proteins
AU9128798A (en) Genotyping of human cyp3a4
IL135867A0 (en) Disposable underpants
AU3789399A (en) Indolicidin analogs and methods of using same
GB9719238D0 (en) Viral infection of cells
IL124387A0 (en) Preparation of 5-Methyleneoxazolines
GB2329384B (en) Preparation of 1-chloro-1-cyclopropylethene
GB2322372B (en) Preparation of 2-Mercaptothiazole
AU2679797A (en) Improved utilization of virus
ZA986546B (en) Purification of propylene oxide
TW312301U (en) Improved structure of earmask
TW319017U (en) Improved structure of mousetraps
GB9713139D0 (en) Use of enzymes
TW321834U (en) Improved structure of balance
IL125503A0 (en) Crystalline forms of progestagens
TW328252U (en) Improved structure of pliers
TW392679U (en) Structure of desiccative pack
TW323471U (en) Improved structure of hairclip
TW317745U (en) Improved structure of mini-duster
TW312131U (en) Improved structure of earflaps
TW313845U (en) Improved structure of pacifier
TW310617U (en) Improved structure of brick group
GB9712349D0 (en) Floristry aids
TW339758U (en) Improved structure of an airtight can
TW344366U (en) Improved structure of sealed can

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)